INS and type 2 diabetes mellitus: In patients with T2D, the defective secretion of insulin by the pancreatic islets relative to the prevailing glucose concentrations could be either due to the decreased secretory rate of the individual β-cells, due to the reduced total β-cell number and/or size, or due to a combination of these two factors (Figure 3) [17,18,19].